OpenURL Connection Search

Select item for more details and to access through your institution.

How to choose between curative radiotherapy or chemotherapy in low stage MCL?—a population‐based analysis of outcome in patients with stage I‐II MCL in Sweden.
Published in:
Hematological Oncology, 2023, v. 41, p. 476, doi. 10.1002/hon.3164_350
By:
- Albertsson‐Lindblad, A.;
- Ekberg, S.;
- Glimelius, I.;
- Ellin, F.;
- Sonnevi, K.;
- Lewerin, C.;
- Smedby, K. E.;
- Jerkeman, M.
Publication type:
Article
Trends in relative survival of Diffuse large B‐cell lymphoma in Sweden in the era of targeted and cellular therapies.
Published in:
Hematological Oncology, 2023, v. 41, p. 429, doi. 10.1002/hon.3164_316
By:
- Smedby, K. Ekström;
- Antonilli, S.;
- Enblad, G.;
- Sonnevi, K.;
- Wahlin, B. E.;
- Andersson, P.;
- Jerkeman, M.;
- Eloranta, S.
Publication type:
Article
Genetic and transcriptomic analyses of diffuse large B‐cell lymphoma patients with poor outcomes within two years of diagnosis.
Published in:
Hematological Oncology, 2023, v. 41, p. 302, doi. 10.1002/hon.3164_211
By:
- Ren, W.;
- Own, S. A.;
- Wan, H.;
- Berglund, M.;
- Wang, X.;
- Yang, M.;
- Li, X.;
- Liu, D.;
- Sonnevi, K.;
- Enblad, G.;
- Amini, R.;
- Sander, B.;
- Wu, K.;
- Zhang, H.;
- Wahlin, B. E.;
- Smedby, K. E.;
- Pan‐Hammarström, Q.
Publication type:
Article
EARLY PROGRESSION OF MANTLE CELL LYMPHOMA DEPICTS A HIGH‐RISK DISEASE WITH POOR RESPONSE TO SUBSEQUENT THERAPIES AND A DISMAL OUTCOME.
Published in:
Hematological Oncology, 2019, v. 37, p. 242, doi. 10.1002/hon.52_2630
By:
- Eskelund, C.W.;
- Kolstad, A.;
- Glimelius, I.;
- Räty, R.;
- Gjerdrum, L.R.;
- Sonnevi, K.;
- Josefsson, P.;
- Nilsson‐Ehle, H.;
- Bentzen, H.;
- Fagerli, U.;
- Kuittinen, O.;
- Haaber, J.;
- Pedersen, L.B.;
- Larsen, M.T.;
- Geisler, C.H.;
- Hutchings, M.;
- Jerkeman, M.;
- Grønbæk, K.
Publication type:
Article
THE CANNABINOID STUDY – 01: INVESTIGATING THE EFFECTS OF CANNABINOIDS IN INDOLENT LEUKEMIC B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 572, doi. 10.1002/hon.20_2632
By:
- Melén, C.M.;
- Merrien, M.;
- Wasik, A.M.;
- Sonnevi, K.;
- Junlén, H.;
- Christensson, B.;
- Sander, B.;
- Wahlin, B.E.
Publication type:
Article
EARLY PROGRESSION OF MANTLE CELL LYMPHOMA DEPICTS A HIGH‐RISK DISEASE WITH POOR RESPONSE TO SUBSEQUENT THERAPIES AND A DISMAL OUTCOME.
Published in:
Hematological Oncology, 2019, v. 37, p. 242, doi. 10.1002/hon.52_2630
By:
- Eskelund, C.W.;
- Kolstad, A.;
- Glimelius, I.;
- Räty, R.;
- Gjerdrum, L.R.;
- Sonnevi, K.;
- Josefsson, P.;
- Nilsson‐Ehle, H.;
- Bentzen, H.;
- Fagerli, U.;
- Kuittinen, O.;
- Haaber, J.;
- Pedersen, L.B.;
- Larsen, M.T.;
- Geisler, C.H.;
- Hutchings, M.;
- Jerkeman, M.;
- Grønbæk, K.
Publication type:
Article
THE CANNABINOID STUDY – 01: INVESTIGATING THE EFFECTS OF CANNABINOIDS IN INDOLENT LEUKEMIC B‐CELL LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 572, doi. 10.1002/hon.20_2632
By:
- Melén, C.M.;
- Merrien, M.;
- Wasik, A.M.;
- Sonnevi, K.;
- Junlén, H.;
- Christensson, B.;
- Sander, B.;
- Wahlin, B.E.
Publication type:
Article
The BioLymph study – implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results.
Published in:
Acta Oncologica, 2023, v. 62, n. 6, p. 560, doi. 10.1080/0284186X.2023.2218556
By:
- Smedby, K. E.;
- Wästerlid, T.;
- Tham, E.;
- Haider, Z.;
- Joelsson, J.;
- Thorvaldsdottir, B.;
- Krstic, A.;
- Wahlin, B. E.;
- Foroughi-Asl, H.;
- Karlsson, C.;
- Eloranta, S.;
- Saft, L.;
- Palma, M.;
- Kwiecinska, A.;
- Hansson, L.;
- Österborg, A.;
- Wirta, V.;
- Rassidakis, G.;
- Sander, B.;
- Sonnevi, K.
Publication type:
Article

Found: 8